At a glance
ClinicalIndex Comparison RecordN/ACompleted· 103 enrolled
Drug / intervention
WIRIONdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of WIRION™ EPS in Lower Extremities Arteries
In Brief
A clinical study evaluating WIRION for Peripheral Arterial Disease (PAD). Completed, enrolled 103 participants across 10 sites in 2 countries.
Detailed Summary
Demonstrate the safety and performance of the WIRION™ EPS in subjects undergoing lower extremity atherectomy for the treatment of Peripheral Arterial Disease (PAD)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease (PAD)
CountriesGermany, United States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMay 2016
First PostedMay 2016
Primary CompletionAug 2017
Study CompletionSep 2017
TodayJul 2026
First PostedMay 23, 2016
Enrollment StartMay 1, 2016
Primary CompletionAug 30, 2017
Study CompletionSep 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.1 years ago
Interventions
WIRIONdevice
Embolic Protection System